CRSPCRISPR Therapeutics AGvs its industry peers
A metric-by-metric comparison of CRISPR Therapeutics AG against ARK Innovation ETF holdings — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CRSPEsta | $5.0B#13 | — | 2.9x#3 | 1427.0x#15 | -90.6%#15 | -58.8%#14 | -18933.6%#15 | -33.3%#13 | -32.6%#6 | — | -10.5%#7 | — |
| TSLA | $1.41T#2 | 330.2x#8 | 16.2x#12 | 14.9x#8 | -2.9%#14 | -46.5%#12 | 4.6%#7 | 4.4%#7 | 4.3%#4 | 5#3 | -13.1%#9 | — |
| TEM | $12M#15 | — | 0.0x#1 | 0.0x#1 | 83.4%#4 | 65.3%#6 | -19.9%#10 | -55.1%#14 | — | — | -19.2%#10 | — |
| AMD | $823.2B#3 | 129.3x#6 | 12.2x#10 | 23.8x#12 | 34.3%#8 | 164.2%#3 | 10.7%#6 | 6.4%#6 | 5.7%#3 | 8#1 | 212.9%#2 | — |
| SHOP | $168.7B#5 | 87.8x#5 | 13.3x#11 | 14.6x#7 | 30.1%#9 | -39.0%#11 | 12.7%#4 | 9.7%#5 | — | — | -12.2%#8 | — |
| ROKU | $23.2B#10 | 66.4x#4 | 8.2x#7 | 4.9x#3 | 15.2%#11 | 168.3%#2 | -0.1%#8 | 3.1%#8 | — | — | 66.8%#3 | — |
| HOOD | $99.3B#6 | 48.9x#3 | 11.6x#9 | 22.2x#10 | 51.6%#6 | 33.5%#8 | 47.1%#1 | 22.0%#2 | — | — | -3.8%#6 | — |
| COIN | $45.4B#7 | — | 3.5x#4 | 6.3x#4 | 9.4%#13 | -50.0%#13 | 20.0%#3 | 9.9%#4 | 10.9%#1 | — | -47.4%#13 | — |
| CRCL | $21.2B#11 | 17.3x#1 | 6.1x#6 | 193.5x#14 | 624.0%#1 | -144.7%#15 | -87.8%#13 | -2.0%#9 | — | — | -35.6%#12 | — |
| PLTR | $414.8B#4 | 147.5x#7 | 42.4x#14 | 92.7x#13 | 56.2%#5 | 251.6%#1 | 31.6%#2 | 16.6%#3 | — | — | 0.8%#5 | — |
| RBLX | $35.9B#9 | — | 236.1x#15 | 7.3x#5 | 35.8%#7 | -13.9%#9 | -25.2%#11 | -705.3%#15 | -724.9%#9 | — | -63.4%#14 | — |
| BEAM | $2.4B#14 | — | 2.3x#2 | 17.2x#9 | 120.0%#3 | 78.8%#5 | -274.6%#14 | -7.5%#10 | -40.5%#7 | — | — | — |
| TWST | $8.6B#12 | — | 19.4x#13 | 23.0x#11 | 20.3%#10 | 62.8%#7 | -36.2%#12 | -17.4%#11 | -41.4%#8 | — | 435.7%#1 | — |
| CRWV | $43.6B#8 | — | 8.7x#8 | 8.5x#6 | 167.9%#2 | -35.3%#10 | -0.9%#9 | -23.2%#12 | -0.2%#5 | — | -32.8%#11 | — |
| AMZN | $2.68T#1 | 20.0x#2 | 4.9x#5 | 3.7x#2 | 12.4%#12 | 91.6%#4 | 11.2%#5 | 24.5%#1 | 10.7%#2 | 6#2 | 7.3%#4 | — |
Peer set: top holdings of ARKK (ARK Innovation ETF), the indexed fund holding this stock at its highest weight — a fund manager's grouping, not Tickwind's judgement. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-09-15.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice